- Home
- AME vs RGC Comparison
AME vs RGC Comparison
Compare AME & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AME
- RGC
- Stock Information
- Founded
- AME 1930
- RGC 2014
- Country
- AME United States
- RGC Hong Kong
- Employees
- AME N/A
- RGC N/A
- Industry
- AME Industrial Machinery/Components
- RGC Medicinal Chemicals and Botanical Products
- Sector
- AME Industrials
- RGC Health Care
- Exchange
- AME Nasdaq
- RGC Nasdaq
- Market Cap
- AME 41.7B
- RGC 38.6B
- IPO Year
- AME N/A
- RGC 2021
- Fundamental
- Price
- AME $182.00
- RGC $10.36
- Analyst Decision
- AME Buy
- RGC
- Analyst Count
- AME 8
- RGC 0
- Target Price
- AME $200.14
- RGC N/A
- AVG Volume (30 Days)
- AME 1.3M
- RGC 1.6M
- Earning Date
- AME 07-31-2025
- RGC 06-30-2025
- Dividend Yield
- AME 0.68%
- RGC N/A
- EPS Growth
- AME 7.39
- RGC N/A
- EPS
- AME 6.11
- RGC N/A
- Revenue
- AME $6,936,971,000.00
- RGC N/A
- Revenue This Year
- AME $2.56
- RGC N/A
- Revenue Next Year
- AME $4.65
- RGC N/A
- P/E Ratio
- AME $29.83
- RGC N/A
- Revenue Growth
- AME 2.98
- RGC N/A
- 52 Week Low
- AME $145.02
- RGC $0.08
- 52 Week High
- AME $198.33
- RGC $83.60
- Technical
- Relative Strength Index (RSI)
- AME 58.95
- RGC 42.04
- Support Level
- AME $179.51
- RGC $17.00
- Resistance Level
- AME $183.97
- RGC $34.58
- Average True Range (ATR)
- AME 2.62
- RGC 12.29
- MACD
- AME 0.27
- RGC -3.56
- Stochastic Oscillator
- AME 79.26
- RGC 1.31
About AME AMETEK Inc.
Founded in 1930 and transformed over the decades through the acquisition of dozens of esteemed brands, Ametek owns a collection of over 40 autonomous industrial businesses operating within the research, aerospace, energy, medical, and manufacturing industries. Ametek segments its business into two operating groups: the electronic instruments group and the electromechanical group. The EIG sells a broad portfolio of analytical, test, and measurement instruments, while the EMG sells highly engineered components, interconnects, and specialty metals. The company emphasizes product differentiation and market leadership in the niche markets where it operates.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.